Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
23.52
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 16, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today
December 15, 2022
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the...
Via
Benzinga
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
December 15, 2022
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.
Via
Investor's Business Daily
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
December 15, 2022
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
8 Analysts Have This to Say About Guardant Health
November 18, 2022
Via
Benzinga
Expert Ratings for Guardant Health
November 18, 2022
Via
Benzinga
Stephens Starts Coverage On This Precision Oncology Company With 66% Upside
October 06, 2022
Via
Benzinga
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
December 15, 2022
From
Guardant Health, Inc.
Via
Business Wire
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
These two companies are just getting started.
Via
The Motley Fool
Guardant Health Announces Collaboration With AstraZeneca to Develop Companion Diagnostic to Identify Patients With ESR1-mutated Metastatic Breast Cancer
December 08, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
December 01, 2022
From
Guardant Health, Inc.
Via
Business Wire
Analyst Ratings for Guardant Health
October 06, 2022
Analysts have provided the following ratings for Guardant Health (NASDAQ:GH) within the last quarter:
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
November 22, 2022
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Via
Benzinga
Guardant Health Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Guardant Health, Inc.
Via
Business Wire
Where Guardant Health Stands With Analysts
November 01, 2022
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Why Guardant Health Stock Fell 5.5% Today
October 19, 2022
Is Guardant Health as obvious a bargain as this analyst makes it out to be?
Via
The Motley Fool
Guardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
October 10, 2022
From
Guardant Health, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Upgrades
Via
Benzinga
Why Guardant Health Topped the Market on Thursday
October 06, 2022
Add another name to the list of the cancer-diagnostic company's bulls.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Upgrades
Via
Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...
Via
Benzinga
Guardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner
September 09, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients
September 06, 2022
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.